Vol. 18/No. 18 | OncologyLive

Novel Radiation Oncology Research Makes Population Health Strategies Smarter

September 26, 2017

For the past 5 years, Montefiore has been a leading Pioneer Accountable Care Organization (ACO) in CMS’ ACO program, which aims to improve the quality of care for Medicare beneficiaries while identifying ways to save healthcare dollars.

Immunotherapy Paradigm Continues to Evolve in NSCLC

September 24, 2017

Recent approval of immunotherapy in the first-line setting for treatment of patients with locally advanced and metastatic non–small cell lung cancer without driver mutations represents changes in care.

Through the ASCO Lens: A Perspective on the Present and Future of Oncology

September 23, 2017

The clinical oncology community, along with patients, families, pharmaceutical companies, investors, and third-party payers, eagerly awaits the plenary session presentations at the ASCO annual meetings as representing the most important and impactful of the thousands of abstracts submitted each year.

EZH2 Emerges as Epigenetic Target

September 22, 2017

EZH2 have been frequently observed in cancer, and small molecule inhibitors have been developed against the enzymatic activity of EZH2, with evidence of clinical activity in early-phase trials.